About this scholarly article

Bevacizumab Plus Erlotinib Is Active in the Treatment of Patients with Carcinomas of Unknown Primary Site, is a scholarly article available to read on EtoBox.

Publisher

Adis International Limited (now part of Wolters Kluwer Health); Springer-Verlag; Springer Science and Business Media LLC (ISSN 1173-8324)

Published

2007